Executive Summary
Core view: Q1 revenue rose 70.9% and EBITDA 98%, but Hobel was consolidated from 1 May, so growth is inorganic and not like-for-like. A ₹280.3 crore order book, 96% exports and underused capacity support growth; integration and valuation are the central risks.
Unimech makes aero-engine and MRO tooling, precision components and assemblies for aerospace, nuclear, semiconductor and energy customers. Hobel Bellows adds engineered bellows and adjacency, but acquisition funding and integration change the group's return profile.
Q1 FY27 Snapshot
Revenue₹107.62 Cr+70.9% YoY
EBITDA₹39.25 Cr+98% YoY
EBITDA margin36.5%vs 31.4% YoY
PAT₹27.86 Cr+45.7% YoY
Hobel was consolidated only from 1 May 2026, contributing two months to Q1. The reported 70.9% revenue growth is therefore inorganic and not a clean organic comparison.
Business Position
Strengths
- High-precision aerospace and MRO tooling qualifications.
- About 96% exports across eight countries at June 2026.
- Five facilities plus FTW and over 150 CNC machines.
- Combined order book of ₹280.3 crore.
Constraints
- Hobel makes Q1 growth non-comparable.
- Customer approvals and qualifications are lengthy.
- FY26 returns were only 8.0% ROE and 11.2% ROCE.
- ₹450 crore acquisition and Saudi JV raise capital demands.
Growth Drivers And Capacity Economics
| Driver | Evidence | Investment test |
|---|---|---|
| Serial aerospace work | FACC LTA and global OEM/Tier-1 programmes | Qualifications must convert into recurring production revenue. |
| Hobel Bellows | ₹450 crore acquisition; ₹100.1 crore backlog | Cross-selling and utilization must offset funding and integration cost. |
| Nuclear | ₹87.3 crore order within group backlog | Execution should diversify aerospace concentration. |
| Saudi JV | About US$30 million planned investment | Local presence must deliver contracts before depressing returns. |
The group has roughly 5.6 lakh sq ft and around 60% utilization. That offers operating leverage, but the ₹180.2 crore Unimech and ₹100.1 crore Hobel backlogs must convert without margin erosion.
Management Guardrails And Credibility
| Operating objective | Status | Evidence required |
|---|---|---|
| Deliver strong growth | Reported growth strong | Organic and Hobel contributions need separate disclosure. |
| Improve utilization | Opportunity | Combined utilization should rise from roughly 60%. |
| Integrate Hobel | Early stage | Margins, retention, cross-selling and cash flow should remain healthy. |
| Build Saudi presence | Planned | Capital deployment should follow customer commitments. |
No numerical FY27 revenue guidance was disclosed. Forecasts should therefore be treated as scenarios anchored to backlog, capacity and acquisition timing rather than management targets.
Financial Quality
FY26 revenue₹240 CrSlightly below FY25
FY26 PAT₹63 Cr-24% YoY
FY26 borrowings₹127 CrBefore full integration
FY26 CFO₹61 CrNear reported PAT
| Quality test | Reading | Interpretation |
|---|---|---|
| ROCE | 11.2% | Needs improvement as capacity and acquisition capital are utilized. |
| Cash conversion | CFO ₹61 crore versus PAT ₹63 crore | Reasonable FY26 conversion before Hobel consolidation. |
| Margins | 36.5% Q1 EBITDA margin | Strong, but must hold after a full quarter of acquired operations. |
| Exports | 96% at June 2026 | Global positioning is attractive but concentrated. |
Valuation
At ₹1,610 on 11 September 2026, market capitalization was approximately ₹8,195 crore and trailing P/E about 113.8x. The valuation requires a substantial improvement from FY26 revenue and returns.
| Scenario | FY28 revenue | PAT margin | Illustrative PAT | Current market-cap / PAT |
|---|---|---|---|---|
| Bear | ₹420 Cr | 18% | ₹76 Cr | 108x |
| Base | ₹500 Cr | 22% | ₹110 Cr | 75x |
| Bull | ₹600 Cr | 25% | ₹150 Cr | 55x |
Even the bull case assumes successful integration, higher utilization and sustained margins. The market price leaves little room for qualification delays or capital-allocation errors.
Key Risks
- Hobel integration disrupts margins, customers or cash generation.
- Reported growth is mistaken for organic growth.
- Aerospace approvals delay serial production.
- Customer and export concentration amplify programme risk.
- Saudi investment dilutes already modest returns.
Annual Projection
| Period | Revenue | EBITDA margin | PAT | Key condition |
|---|---|---|---|---|
| FY27E | ₹408-443 Cr | 36-38% | ₹98-113 Cr | Hobel integrates and combined backlog converts. |
| FY28E | ₹460-540 Cr | 36-39% | ₹105-135 Cr | Serial production and utilization rise. |
| FY29E | ₹550-675 Cr | 37-40% | ₹135-180 Cr | Nuclear, semiconductor and Saudi opportunities scale. |
These are analytical scenarios, not management guidance. EPS uses approximately 5.09 crore shares and assumes no material new dilution.
Investor Watchlist
- Organic Unimech growth versus Hobel contribution.
- Combined order book and conversion.
- Utilization, EBITDA margin and operating cash flow.
- Hobel integration milestones and cross-selling.
- Saudi JV commitments and return on capital.
Sources Used
Prepared on 13 September 2026 from public information. Forecasts are analytical estimates and not investment advice.